Download Full Text (214 KB)


Type 2 Diabetes Mellitus is one of the most common metabolic disorders worldwide (Galicia-Garcia et al., 2020). The development of Type 2 Diabetes is primarily caused by a combination of: Defective insulin secretion by pancreatic β-cells (Galicia-Garcia et al., 2020). The inability of insulin-sensitive tissues to respond to insulin (Galicia-Garcia et al., 2020). Type 2 diabetes is a disease of insulin resistance (Jacobs et al., 2018). According to Khan and colleagues (2019), in 2017 it was estimated that 462 million individuals globally are affected by type 2 diabetes or 6.28% of the world’s population. By 2035, it is estimated that there will be >590 million individuals diagnosed with type 2 diabetes (Reed et al., 2021). The prevalence of type 2 diabetes is greatest in African Americans Hispanic Americans (Jacobs et al., 2018). Medical therapy for type 2 diabetes is mostly used to improve insulin resistance, reduce liver secretion of glucose, and stimulate pancreatic beta cells to secrete insulin (Jacobs et al., 2018). Lifestyle has been shown to be more effective in reducing the risk for developing type 2 diabetes (Jacobs et al., 2018). It takes up to 10 years for insulin resistance to progress to diagnosis of type 2 diabetes (Jacobs et al., 2018). Over 75% of type 2 diabetes cases are among obese, inactive adults (Jacobs et al., 2018)

Publication Date

Spring 2022


Boiling Springs, NC


Medicine and Health Sciences | Movement and Mind-Body Therapies | Rehabilitation and Therapy | Sports Sciences

The Benefits of Exercise in Individuals with Type II Diabetes